Search results
US nears deal to fund Moderna’s bird flu vaccine trial, FT reports
KFGO· 1 day ago(Reuters) - The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 1 day agoThe U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu...
Moderna's stock climbs on report that bird-flu vaccine funding is near
Morningstar· 22 hours agoModerna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu ...
What’s next for bird flu vaccines
Technology Review· 5 hours agoMost of the flu virus used in vaccines is grown in eggs, but there are alternatives. The seasonal flu vaccine Flucelvax, produced by CSL Seqirus, is...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 3 days agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
Moderna rises on FT report about bird flu vaccines By Investing.com
Investing.com· 24 hours agoShares of Moderna (NASDAQ:MRNA) are up 2.8% premarket Thursday after a report from The Financial...
Moderna and this solar name are among the most overbought stocks after a record-setting week
CNBC· 7 days agoIt may be time for investors to trim positions in overbought names after the stock market reached...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Salesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise By Investing.com
Investing.com· 24 hours agoSalesforce, Kohl's and Agilent fall premarket; Foot Locker, Moderna rise
US nears deal to fund Moderna's bird flu vaccine trial, FT reports By Reuters
Investing.com· 1 day agoModerna and the U.S. Department of Health and Human Services (HHS) did not immediately respond to...
